Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Crispr Therapeutics Ag (NQ: CRSP )

55.90 +0.83 (+1.51%)
Streaming Delayed Price Updated: 1:48 PM EDT, May 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 922,264
Open 56.70
Bid (Size) 55.90 (1)
Ask (Size) 55.94 (2)
Prev. Close 55.07
Today's Range 55.57 - 58.45
52wk Range 37.55 - 91.10
Shares Outstanding 78,935,098
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Growth Stocks You’ll Kick Yourself for Not Buying Today
Netflix, Intuit, and Vertex Pharmaceuticals are three growth stocks to buy, each positioned for significant market share and returns. 
Via InvestorPlace
3 Biotech Stocks to Buy and Hold Through 2030 and Beyond
It pays to develop novel medicines for life-threatening illnesses. 
Via The Motley Fool

Performance

YTD
-15.38%
-15.38%
1 Month
-14.04%
-14.04%
3 Month
-13.56%
-13.56%
6 Month
+21.05%
+21.05%
1 Year
+13.64%
+13.64%

More News

Read More
3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire
Via InvestorPlace
Stock Market Crash Alert: 3 Must-Buy Biotech Stocks When Prices Plunge
Via InvestorPlace
Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.
Via The Motley Fool
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,000 Today
Via Benzinga
Is It Too Late to Buy CRISPR Therapeutics Stock?
Via The Motley Fool
Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy?
Via The Motley Fool
3 Magnificent Stocks That Could Double or More by 2030
Via The Motley Fool
Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024
Via InvestorPlace
Better Buy: CRISPR Therapeutics Vs. Viking Therapeutics
Via The Motley Fool
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
Via The Motley Fool
Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics
Via The Motley Fool
3 Unstoppable Stocks to Buy Hand Over Fist in April
Via The Motley Fool
Crispr Stock, A Cathie Wood Holding, Dives For The Fifth Straight Week — Here's Why
Via Investor's Business Daily
3 Biotech Stocks That Could Be Multibaggers in the Making: March Edition
Via InvestorPlace
3 No-Brainer Healthcare Stocks to Buy Right Now for Less Than $1,000
Via The Motley Fool
Buying These Dirt-Cheap Stocks Could Be a Brilliant Move
Via The Motley Fool
3 Stocks That Could Be the Next Big Thing in Gene Editing
Via InvestorPlace
Geron Stock Doubles After Imetelstat Receives FDA Panel Approval
Via MarketBeat
Exposures Product Safety
The 3 Most Undervalued Cathie Wood Stocks to Buy in March 2024
Via InvestorPlace
7 Biotech Stocks to Buy as Sector Rotation Ramps Up
Via InvestorPlace
Cathie Wood's Ark Invest Keeps Dumping Coinbase Shares Amid Bitcoin, Crypto Buzz
Via Benzinga
It's A Bull Market But Harder To Pick Small Cap Biotech Winners Because Of Volatility
Via Talk Markets
The Top 3 Biotech Stocks to Buy in March 2024
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.